Genfit S.A. (GNFT.PA)
Develops medicines and diagnostic tests for liver and metabolic diseases.
13.20-0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+291.9%
The outlook
GNFT.PA is trading at 13.2, well above both its 50- and 200-day moving averages and near the top of its 52-week range. Analyst consensus sits roughly 20% above the current price. The overall sentiment leans bullish based on current technical positioning and target levels.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range90% of the way from its 52-week low to high
Price targetAvg target +20% vs current price
Analyst price target
~12-month · 4 analysts15.90average target+20.5% vs now
Now 13.20
Low 15.00High 18.60
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$661.3M
52-wk high
14.32
52-wk low
3.05
50-day avg
10.74
200-day avg
7.52
Trailing P/E
—